Job Description Summary
The Head of Value & Pricing Spain leads the definition and execution of pricing, value and contracting strategies across the Novartis portfolio in Spain, ensuring an optimal value positioning with payers and authorities, and maximising patient access throughout the product lifecycle.This role is critical in engaging with the Ministry of Health, regional authorities and key stakeholders, translating clinical and economic evidence into sustainable pricing, access and agreement decisions.
Job Description
Key Responsibilities
1. Pricing & Value Strategy
- Define pricing and value strategies for launches and in-market products, aligned with access and sustainability objectives.
- Lead preparation for price negotiations (CIPM), integrating clinical, economic and value evidence.
- Assess the impact of pricing decisions on access, market share and healthcare system sustainability.
- Contribute to strategic positioning versus competitors in key markets.
- Translate customer and market insights into actionable strategic decisions.
2. Institutional Engagement
- Manage interactions with key payers, providing strong economic and clinical rationale.
- Anticipate and respond to regulatory requirements related to pricing and economic models.
- Act as an internal reference for the regulatory environment (CIPM, reimbursement, pricing confidentiality, etc.).
3. Lifecycle Pricing Management
- Manage pricing across the product lifecycle, including:
- Launches
- Price revisions
- Discounts and agreements
- Impact of loss of exclusivity (LoE)
- Ensure alignment between pricing, forecasting and commercial strategy.
- Ensure effective governance and implementation of pricing changes.
4. Contracting, Access & Tendering
- Design and implement payer agreement strategies (e.g. risk-sharing, expenditure caps).
- Lead commercial policy through innovative agreements and tenders in hospitals and key accounts.
- Oversee operational execution of contracts:
- Negotiation
- Tracking
- Renewals
Supported by appropriate systems and tools.
5. International Pricing & Governance
- Adapt International Pricing Guidance to the Spanish context.
- Ensure alignment between local decisions and global frameworks.
- Coordinate with international teams on:
- Price setting
- External reference pricing impact
- Ensure compliance with pricing systems and processes (e.g. Price Pro, reporting, audits).
6. Cross-functional Leadership
- Lead a pricing and/or contracting team.
- Act as a strategic partner to:
- Market Access Strategy
- HEOR
- Commercial / Therapeutic Areas
- Finance
- Drive a culture of impact and performance.
Profile Requirements
Experience
- 8–10 years’ experience in Market Access, Pricing, HEOR or related areas within the pharmaceutical industry or strategic consulting
- Proven experience leading and developing teams
- Demonstrated experience in:
- Pricing strategy development and market analysis
- Preparation and support of pricing dossiers, business cases or access materials
- Project management in complex, regulated environments
- Experience supporting or collaborating in:
- Pricing and reimbursement processes
- Direct interactions with payers and health authorities
- Exposure to global environments and international pricing/access teams is a plus
- Experience in complex environments and innovative products (oncology, specialty care, etc.)
Key Competencies
- Strategic thinking with strong focus on business impact
- High-level negotiation skills in institutional settings
- Ability to integrate clinical, economic and commercial evidence
- Strong cross-functional leadership without direct authority
- Clear, executive and decision-oriented communication
Technical Background
- Degree in health economics, pharmacy, medicine or similar
- Strong asset: experience in economic modelling / budget impact analysis
- Fluent English
Skills Desired
Access And Reimbursement Strategy, Agility, Analytical Skill, Analytical Thinking, Cross-Functional Collaboration, Customer-Centric Mindset, Employee Development, Finance, Go-To-Market Strategy, Healthcare Sector Understanding, Health Economics, Health Policy, Health Technology Assessment (HTA), Innovation, Inspirational Leadership, Market Access Strategy, Negotiation Skills, People Management, Process Management, Project Management, Public Affairs, Real World Evidence (RWE), Regulatory Compliance, Risk Management, Value PropositionsSkills Required
- 8-10 years experience in Market Access, Pricing, HEOR or related areas
- Proven experience leading and developing teams
- Experience in pricing strategy development and market analysis
- Experience supporting or collaborating in pricing and reimbursement processes
- Fluent English
Novartis Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Novartis and has not been reviewed or approved by Novartis.
-
Healthcare Strength — Pay and benefits are described as a strong overall package, supported by medical, dental, and vision insurance alongside FSAs/HSAs and disability and life coverage. Mental-health support is reinforced through an employee assistance program with psychological support and a network of mental health first aiders.
-
Retirement Support — Retirement support is positioned as a standout element, with an automatic company contribution plus dollar-for-dollar matching in the 401(k). Additional retirement funding is described through an age-based defined contribution program and access to an employee share purchase plan discount.
-
Parental & Family Support — Family-related benefits are framed as robust, including a global minimum of paid parental leave for new parents following birth or adoption. Added supports include domestic partner coverage, dependent-care resources, and benefits such as adoption assistance and child/elder care options.
Novartis Insights
What We Do
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

.png)





